The interplay between thyroid and liver: implications for clinical practice.
Piantanida E, Ippolito S, Gallo D, Masiello E, Premoli P, Cusini C, Rosetti S, Sabatino J, Segato S, Trimarchi F, Bartalena L, Tanda ML.
J Endocrinol Invest. 2020 Jul;43(7):885-899. doi: 10.1007/s40618-020-01208-6. Epub 2020 Mar 12.
Methimazole-induced hepatotoxicity.
Woeber KA.
Endocr Pract. 2002 May-Jun;8(3):222-4. doi: 10.4158/EP.8.3.222.
Tamoxifen-induced hepatotoxicity.
Ahbeddou N, Belbaraka R, Fetohi M, Errihani H.
Indian J Cancer. 2011 Jul-Sep;48(3):385. doi: 10.4103/0019-509X.84935.
Drug-induced liver injury in pregnancy.
Lao TT.
Best Pract Res Clin Obstet Gynaecol. 2020 Oct;68:32-43. doi: 10.1016/j.bpobgyn.2020.03.005. Epub 2020 Mar 16.
[Hyponatremia].
Haris A, Radó J.
Orv Hetil. 1997 Dec 7;138(49):3087-95.
Leukotriene antagonists.
Davern TJ, Bass NM.
Clin Liver Dis. 2003 May;7(2):501-12, viii. doi: 10.1016/s1089-3261(03)00031-x.
Flutamide-induced hepatotoxicity: ethical and scientific issues.
Giorgetti R, di Muzio M, Giorgetti A, Girolami D, Borgia L, Tagliabracci A.
Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):69-77.
Anastrozole-induced hepatotoxicity.
Zapata E, Zubiaurre L, Bujanda L, Piérola A.
Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1233-4. doi: 10.1097/01.meg.0000243868.64078.af.
Propylthiouracil-induced hepatotoxicity.
Hardee JT, Barnett AL, Thannoun A, Eghtesad B, Wheeler D, Jamal MM.
West J Med. 1996 Sep;165(3):144-7.
Spironolactone-induced hepatitis.
Thai KE, Sinclair RD.
Australas J Dermatol. 2001 Aug;42(3):180-2. doi: 10.1046/j.1440-0960.2001.00510.x.
